Medtech Canada Sector Advisory on Middle East Disruptions and Sector Cost Pressures

Following feedback from our recent member survey regarding the impacts of the ongoing conflict and shipping disruptions in the Middle East, Medtech Canada has released a sector advisory titled: "Geopolitical Conflicts in the Middle East and Its Cumulative Financial Burden on Canadian Medical Technology Suppliers."

What the Sector Advisory Addresses

While Canadian medtech companies continue to do everything possible to safeguard product availability and patient care, our industry is absorbing substantial, unbudgeted cost spikes:

• Raw Material and Energy Inflation: Surging energy and petroleum prices are driving substantial cost increases for critical inputs like polymers, oncology-grade nitrile gloves, and single-use consumables.
• Escalating Freight and Surcharges: Severe maritime container constraints and mandatory fuel surcharges on inbound materials and outbound distribution are straining domestic operating margins.
• Clinical and Regulatory Realities: Complex hospital validation protocols and Standard Operating Procedures (SOPs) prevent rapid, low-cost product substitution, leaving vendors uniquely vulnerable under rigid, fixed-price contracts.

Advocating for Procurement Flexibility
Through this document, Medtech Canada is formally calling on health system buying partners to collaborate with suppliers through:

1. Contractual Adaptability: Establishing relief provisions, such as fuel surcharge sharing and freight adjustments, to mitigate extraordinary geopolitical shocks.
2. Open Dialogue: Engaging proactively with vendor partners to evaluate macroeconomic pressures pragmatically and protect the long-term sustainability of the Canadian supply chain.

Access the Document

You can read and download the full sector advisory here:

Geopolitical Conflicts in the Middle East and Its Cumulative Financial Burden on Canadian Medical Technology Suppliers